Montelukast Inhibits Lung Cancer Cell Migration by Suppressing Cysteinyl Leukotriene Receptor 1 Expression In vitro

BACKGROUND: Lung cancer is a major threat to public health and remains difficult to treat. Repositioning of existing drugs has emerged as a therapeutic strategy in lung cancer. Clinically, low-dose montelukast has been used to treat asthma. OBJECTIVE: We evaluated the potential of using montelukast...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yisheng, Zhang, Jinye, Wei, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Biotechnology, Applied Microbiology, Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286556/
https://www.ncbi.nlm.nih.gov/pubmed/36503460
http://dx.doi.org/10.2174/1389201024666221207143513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286556/
https://www.ncbi.nlm.nih.gov/pubmed/36503460
http://dx.doi.org/10.2174/1389201024666221207143513

Ejemplares similares